Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-015454
Filing Date
2017-04-10
Accepted
2017-04-10 17:04:03
Documents
1
Period of Report
2017-04-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4781
  Complete submission text file 0001140361-17-015454.txt   6417
Mailing Address 834-F SOUTH PERRY STREET, SUITE 443 CASTLE ROCK CO 80104
Business Address 834-F SOUTH PERRY STREET, SUITE 443 CASTLE ROCK CO 80104 303-794-2000
Bioptix, Inc. (Issuer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1170 PEACHTREE ST. SUITE 525 ATLANTA GA 30309
Business Address
Beeghley Michael Martin (Reporting) CIK: 0001662216 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33675 | Film No.: 17754171